[company_age]2.0[/company_age][employees]11-50 employees[/employees][funding]non_equity_assistance[/funding][description]Ad Astra Diagnostics, Inc. is a medical technology company that develops and manufactures rapid diagnostic tests for use in healthcare settings. The company's flagship product is the QScout™ RLD, a rapid leukocyte differential test that provides a white blood cell and differential count at patient-side in about 2 minutes from a drop of blood. The QScout™ RLD is an imaging-based system that uses artificial intelligence to examine cells directly, instead of relying on indirect measures like light scatter or electrical resistance. This makes the QScout™ RLD more accurate and reliable than traditional methods, and it also eliminates the need for lengthy machine startup time or sample prep. Ad Astra Diagnostics is committed to providing healthcare professionals with the information they need to make informed decisions about patient care. The company's products are used in a variety of settings, including hospitals, clinics, and physician offices. Ad Astra Diagnostics is headquartered in Morrisville, North Carolina.[/description][ps]QScout™ RLD[/ps]